NovaBay Receives Unique Globally Recognized International Nonproprietary Name Auriclosene for NVC-422

[at noodls] – – Data from Three Phase 2 Trials of Lead Aganocide Compound Anticipated in 2013 – – Phase 3 Registration Trials Expected in 2014 – EMERYVILLE, CA – February 20, 2013 – NovaBay® Pharmaceuticals, Inc. (NYSE … more

View todays social media effects on NBY

View the latest stocks trending across Twitter. Click to view dashboard

See who NovaBay is hiring next, click here to view